Stage-specific antimalarial activity of cysteine protease inhibitors

Biological Chemistry

Volumn 383, Issue 5, 2002, Pages 843-847

  Shenai, Bhaskar R ^a   Semenov, Andrey V ^a   Rosenthal, Philip J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chemotherapy; Malaria; Plasmodium; Protease; Proteinase

Indexed keywords

ANTIMALARIAL AGENT; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; HEMOGLOBIN; KETONE DERIVATIVE; LEUPEPTIN; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; DRUG DERIVATIVE; FALCIPAIN; LEUCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG TARGETING; ENZYME ACTIVITY; MOUSE; NONHUMAN; PARASITE CULTIVATION; PARASITE DEVELOPMENT; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN HYDROLYSIS; TROPHOZOITE; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; ENZYMOLOGY; ERYTHROCYTE; GENE EXPRESSION REGULATION; GROWTH, DEVELOPMENT AND AGING; HYDROLYSIS; METABOLISM; PARASITOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; TIME;

ANIMAL; ANTIMALARIALS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ERYTHROCYTES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEMOGLOBINS; HYDROLYSIS; LEUCINE; LEUPEPTINS; PLASMODIUM FALCIPARUM; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS; ANIMALS;

ANIMALIA; PLASMODIUM FALCIPARUM;

EID: 0035985069     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2002.089     Document Type: Article

References (26)

1. Plasmodium falciparum: Differential sensitivity in vitro to E-64 (cysteine protease inhibitor) and pepstatin A (aspartyl protease inhibitor)
2. Sequence, expression and modeled structure of an aspartic proteinase from the human malaria parasite Plasmodium falciparum
3. Recombinant falcipain-2 cleaves erythrocyte membrane ankyrin and protein 4.1
4. Identification and characterization of falcilysin, a metallopeptidase involved in hemoglobin catabolism within the malaria parasite Plasmodium falciparum
5. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum
6. Cysteine proteinase inhibitors block early steps in hemoglobin degradation by cultured malaria parasites
7. Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway
8. Hemoglobin degradation in the human malaria pathogen Plasmodium falciparum: A catabolic pathway initiated by a specific aspartic protease
9. Plasmodium knowlesi: Studies on invasion of rhesus erythrocytes by merozoites in the presence of protease inhibitors
10. High level expression and characterisation of plasmepsin II, an aspartic proteinase from Plasmodium falciparum
11. Synchronization of Plasmodium falciparum erythrocytic stages in culture
12. Malaria, the submerged disease
13. Antimalarial effects in mice of orally administered peptidyl cysteine protease inhibitors
14. A cysteine protease activity from Plasmodium falciparum cleaves human erythrocyte ankyrin
15. Structure-based inhibitor design by using protein models for the development of antiparasitic agents
16. Hemoglobin catabolism and iron utilization by malaria parasites
17. Identification of three stage-specific proteinases of Plasmodium falciparum
18. A malarial cysteine protelnase is necessary for hemoglobin degradation by Plasmodium falciparum
19. Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase
20. Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria
21. Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors
22. Neutral proteases involved in the reinvasion of erythrocytes by Plasmodium merozoites
23. Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum
24. Expression and characterization of the Plasmodium falciparum hemoglobinase falcipain-3
25. Human malaria parasites in continuous culture
26. Stage-dependent effects of chloroquine on Plasmodium falciparum in vitro